
Skye Bioscience
Unlocking the pharmaceutical potential of the endocannabinoid system.
Market cap
$129m
Enterprise value
$70m
Share price
$4.18 SKYE
Recent deals
Authorizing premium user...
Unlocking the pharmaceutical potential of the endocannabinoid system.